The hiccup reflex arc involves the phrenic nerve (C3–C5 — diaphragm), vagus nerve (gastric, oesophageal, thoracic branches), and a putative "hiccup centre" in the upper cervical spinal cord and brainstem (nucleus tractus solitarius, reticular formation). Any structure along this arc — from the gastric fundus to the brainstem — can trigger hiccups. Many patients with hiccups lasting >48 hours have an identifiable cause, most commonly gastrointestinal (GORD, gastric distension, oesophageal pathology), CNS, metabolic (uraemia, hyponatraemia, hypocalcaemia), or drug-related. The definition of hiccup duration is clinically important: acute hiccups last <48 hours (benign, self-limiting, usually gastrointestinal trigger), persistent hiccups last 48 hours to 1 month (investigate), intractable hiccups last >1 month (need fuller specialist assessment — CNS, malignancy, metabolic or refractory GORD are possible, though some remain idiopathic). Dexamethasone is an important cause in oncology patients — review need, dose and timing with the oncology or palliative team rather than changing it alone.

GORD (gastro-oesophageal reflux disease) is the most commonly identifiable cause of persistent hiccups in primary care — the mechanism is oesophageal irritation stimulating the vagal branches that form part of the hiccup reflex arc. Where reflux features are present, a PPI trial is reasonable. Alcohol is a common and underappreciated cause of persistent hiccups — both through acute gastric distension/irritation and through its CNS depressant effects on the hiccup inhibitory pathways. A careful alcohol history should be taken in all patients with persistent hiccups. Post-operative hiccups are a recognised complication of abdominal and thoracic surgery, and of general anaesthesia (thought to be due to direct diaphragmatic irritation, gastric distension from air swallowing, and anaesthetic agent effects). They can significantly impair wound healing, nutrition, and sleep in post-operative patients and require active management.

Whether hiccups persist in sleep can be a clue, but it does not reliably separate organic from functional causes. The Arnold's nerve (auricular branch of the vagus) ear reflex is a genuine and often overlooked cause of persistent hiccups — the auricular branch of CN X innervates the posterior external auditory canal, and stimulation (by wax, a hair, a foreign body) causes reflex vagal activation. This is rare; inspection is reasonable in unexplained persistent hiccups, but wax removal is not a reliable treatment.

A chest X-ray is often useful in unexplained persistent hiccups — it can identify lung cancer, mediastinal lymphadenopathy (lymphoma), pleural effusion (malignant or inflammatory), pericardial effusion, an elevated hemidiaphragm (phrenic nerve palsy from any cause — tumour, trauma, aortic aneurysm), and cardiomegaly (heart failure causing hiccups through vagal stimulation). Use it by indication rather than universally. Calcium is a reasonable check because hypocalcaemia is a reversible cause. Uraemia causes hiccups through direct irritation of the diaphragm by retained uraemic toxins — this is a relatively specific symptom of advanced uraemia (along with uraemic frost, pericarditis, and encephalopathy) and may indicate a patient with known CKD has deteriorated. Prompt checking of U&E in a CKD patient with new persistent hiccups is always warranted.

The oesophageal suspected cancer pathway is triggered by persistent hiccups combined with dysphagia because dysphagia is itself an NG12 criterion, and hiccups are a recognised early symptom of oesophageal cancer through vagal and phrenic nerve irritation by the tumour. NICE NG12 (updated April 2026) specifies a suspected cancer pathway referral for oesophageal or stomach cancer for anyone with dysphagia at any age, or aged 55 and over with weight loss plus upper abdominal pain, reflux or dyspepsia (this replaced urgent direct-access endoscopy in 2025); at 55 and over, nausea or vomiting with weight loss, reflux, dyspepsia or upper abdominal pain is a consider non-urgent direct-access endoscopy criterion. Persistent hiccups in this context lower the threshold further. Intractable hiccups in palliative patients require specific management — they cause profound deterioration in quality of life through sleep deprivation, poor nutrition (inability to eat comfortably), pain (intercostal muscle fatigue), social isolation, and psychological distress. Drug choice follows the mechanism and the local palliative protocol. A palliative care specialist should be involved in managing intractable hiccups in any seriously ill patient.

Baclofen is the drug most often recommended for persistent hiccups — a systematic review (Steger et al, Aliment Pharmacol Ther 2015) found small randomised placebo-controlled trials supporting baclofen and metoclopramide, although the Cochrane review (Moretto et al, 2013) judged the evidence insufficient to guide treatment. Its mechanism is suppression of the hiccup reflex arc at the level of the medullary reticular formation via GABA-B receptor agonism. The key clinical consideration is renal dosing — baclofen is almost entirely renally excreted and accumulates in renal impairment, causing profound CNS toxicity (drowsiness, confusion, respiratory depression, coma). In advanced CKD, avoid baclofen or use it only with specialist advice. Chlorpromazine holds a UK licence for intractable hiccup (check the current SPC), which is historically significant — it was discovered during the 1950s phenothiazine drug development era and recognised as effective for hiccups before its antipsychotic use became dominant. However its extensive side effect profile (orthostatic hypotension, sedation, extrapyramidal effects, QT prolongation, neuroleptic malignant syndrome) means it is now reserved for severe or refractory cases where other agents have failed. Haloperidol is preferred in palliative care because it can be given subcutaneously and has a more acceptable side effect profile at the low doses used for hiccups.

Opioid rotation for drug-induced hiccups is an important palliative care principle — different opioids have different side effect profiles due to differences in their receptor binding profiles and metabolite activity. A patient on morphine with intractable hiccups may have resolution with a switch to oxycodone or hydromorphone. This is far preferable to adding more drugs, which risks polypharmacy and drug interactions. The dexamethasone timing strategy (morning-only dosing) is based on the understanding that dexamethasone's CNS stimulant and appetite-stimulating effects are most pronounced in the first few hours after dosing — taking it in the morning aligns the peak effect with waking hours and avoids stimulation of the hiccup centre during the evening and night, when hiccups are often most distressing. Any change should be agreed with the oncology or palliative team. Gabapentin is a specialist option in some CNS-related cases, with renal dose adjustment.

The physiological basis for the many hiccup "folk remedies" is now reasonably well understood — the majority work through one of two mechanisms: (1) CO₂ elevation (brief breath-holding) — raised PCO₂ suppresses the phrenic nerve excitability and the respiratory drive component of the hiccup reflex; (2) Vagal stimulation (cold water, swallowing, Valsalva, carotid sinus massage) — activating vagal afferents inhibits the hiccup reflex arc at brainstem level, similar to how a high vagal tone protects against hiccup perpetuation. The HiccAway straw (a straw with an added resistance valve that requires significant subatmospheric pressure to drink through) was marketed as a device that simultaneously performs a Valsalva manoeuvre and engages the swallowing/sucking reflex, but it is not NHS-available and the evidence is low quality. Paper-bag rebreathing is not advised (hypoxia risk, may worsen unrecognised cardiorespiratory illness). For persistent functional/psychogenic hiccups, diaphragmatic breathing retraining is a reasonable non-pharmacological option — it directly targets the respiratory dysrhythmia component and has shown benefit in small case series. A physiotherapist or respiratory physiotherapist with expertise in breathing retraining can provide this formally.

The 48-hour return rule is the most important safety-netting instruction for hiccups — it converts what appears to be a trivial presenting complaint into an appropriately managed clinical problem with a defined escalation trigger. Many serious diagnoses (oesophageal cancer, posterior fossa tumour, pulmonary embolism, uraemia) first present to primary care as "persistent hiccups" and are not diagnosed promptly because the symptom is dismissed. Documenting "hiccups — return if persisting beyond 48 hours; same day if dysphagia or weight loss; 999 if chest pain or new neurological symptoms" in the clinical records both protects the patient and provides appropriate medicolegal documentation. Baclofen discontinuation safety is important — patients are sometimes stopped abruptly when hiccups resolve, which can precipitate withdrawal seizures (baclofen shares this risk with alcohol and benzodiazepines — all act at GABA receptors). Every patient prescribed baclofen should be told not to stop it abruptly, and the taper agreed with the specialist or palliative team should be documented and explained.